- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Transgenomic to Hold Full Year Financial Results Conference Call on April 14, 2016 at 5:00 PM ET
OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Fourth Quarter and Year-End 2015 Financial Results and Business Update Conference Call on Thursday, April 14, 2016 at 5:00 PM ET. The company will present an overview of financial results for the fourth quarter in a press release issued after the market close that day. …
OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Fourth Quarter and Year-End 2015 Financial Results and Business Update Conference Call on Thursday, April 14, 2016 at 5:00 PM ET. The company will present an overview of financial results for the fourth quarter in a press release issued after the market close that day.
To participate in the call, dial 888-632-3381 from the U.S. and Canada, or 785-424-1678 from international locations, and enter conference ID:
TRANS. The call will be webcast live and can be accessed athttps://www.webcaster4.com/Webcast/Page/1139/14570, which is also available at the Investor page of Transgenomic’s website.
A replay will be available for two weeks beginning approximately two after the call’s conclusion, until 11:59 PM ET April 28, 2016. To access the replay, dial 800-839-4012 (domestic) or 402-220-2981
(international). The conference call will also be archived at the Investor section of the company’s website.
About Transgenomic, Inc.
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE
COLD-PCR™. Transgenomic also provides specialized clinical and research to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.